XML 30 R18.htm IDEA: XBRL DOCUMENT
v3.19.1

Derivative Financial Instruments | 3 Months Ended
--- | ---
Mar. 31, 2019
Derivative Financial Instruments [Abstract] |
Derivative Financial Instruments |
9. | Derivative Financial Instruments
The Company enters into non-designated foreign currency derivatives, primarily comprised of foreign currency forward contracts, for which hedge accounting does not apply. The changes in the fair market value of these non-designated derivatives are included in other income/expense in the Company’s consolidated statements of income. The Company uses non-designated foreign currency derivatives to hedge foreign-currency-denominated intercompany transactions and to partially mitigate the impact of foreign-currency fluctuations. The fair value of the non-designated foreign currency derivatives is based on third-party quotes. The following table summarizes gains (losses) related to derivative instruments not designated as hedging instruments during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands):
|  |  |  | Amount of Gain (Loss) Recognized in Income |
Derivatives not Designated |  | Location of Gain (Loss) |  | Three Months Ended March 31, |
as Hedging Instruments: |  | Recognized in Income |  | 2019 |  |  | 2018 |
Foreign currency contracts |  | Other income (expense) |  | $ | — |  |  | $ | — |
The Company designates as cash-flow hedges those foreign currency forward contracts it enters to hedge forecasted intercompany transactions that are subject to foreign currency exposures. Changes in the fair value of these forward contracts designated as cash-flow hedges are recorded as a component of accumulated other comprehensive loss within shareholders’ equity (deficit) and are recognized in the consolidated statement of income during the period which approximates the time the hedged transaction is settled. As of March 31, 2019, the Company held no forward contracts designated as foreign currency cash flow hedges compared to notional amounts of 0.3 billion Japanese yen ($2.8 million) as of March 31, 2018, to hedge forecasted foreign-currency-denominated intercompany transactions. The fair value of these hedges were zero and $(0.1) million as of March 31, 2019 and 2018, respectively. The following table summarizes gains (losses) related to derivative instruments recorded in other comprehensive income (loss) during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands):
|  | Amount of Gain (Loss) Recognized in Other Comprehensive Loss |
Derivatives Designated |  | Three Months Ended March 31, |
as Hedging Instruments: |  | 2019 |  |  | 2018 |
Foreign currency forward contracts related to intercompany license fee, product sales, and selling expense hedges |  | $ | — |  |  | $ | (247 | )
The following table summarizes gains (losses) relating to derivative instruments reclassified from accumulated other comprehensive loss into income during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands):
|  |  |  | Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income |
Derivatives Designated |  | Location of Gain (Loss) Reclassified from Accumulated |  | Three Months Ended March 31, |
as Hedging Instruments: |  | Other Comprehensive Loss into Income |  | 2019 |  |  | 2018 |
Foreign currency forward contracts related to intercompany license fees and product sales hedges |  | Revenue |  | $ | — |  |  | $ | (49 | )
Foreign currency forward contracts related to intercompany selling expense hedges |  | Selling expenses |  | $ | — |  |  | $ | — |
As of March 31, 2019 and December 31, 2018, there were no unrealized gains/(losses) included in accumulated other comprehensive loss related to foreign currency cash flow hedges. The remaining $75.8 million and $79.9 million as of March 31, 2019 and December 31, 2018, respectively, in accumulated other comprehensive loss are related to cumulative translation adjustments. The Company assesses hedge effectiveness at least quarterly. During the three-months period ended March 31, 2018, all hedges were determined to be effective. The Company reports its derivatives at fair value as either other current assets or accrued expenses within its consolidated balance sheet. See Note 7 - Fair Value.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration